MARIETTA, Ga., May 8, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ:MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic
All News
By Varun Saxena The FDA slapped Smith & Nephew ($SNN) with a warning letter for quality-control violations at its Andover, MA, facility related to problems with some of the company’s mechanical morcellators for removal of intrauterine tissue. The company has
November 2014 update: The FDA has approved first-in-human trials for the bridge-enhanced ACL repair technique. A total of 20 patients will participate. Ten will serve as an experimental group and they will undergo a bridge-enhanced ACL repair surgery. …
Today the U.S. Food and Drug Administration approved the Senza spinal cord stimulation (SCS) system (Senza System) as an aid in the management of chronic intractable pain of the trunk and/or limbs, including pain associated with failed back surgery syn…
CONMED Corporation (NASDAQ:CNMD)today announced that it has appointed Peter Shagory as the Company’s Executive Vice President, Strategy and Corporate Development. Mr. Shagory will be responsible for managing CONMED’s global business development and strategic business opportunities. Mr. Shagory brings to CONMED
May 8, 2015 by Brad Perriello Wright Medical and Tornier schedule shareholder votes next month on their pending, $3 billion ‘merger of equals.’ Wright Medical (NSDQ:WMGI) and Tornier (NSDQ:TRNX) yesterday said they scheduled a set of meetings so their shareholders can vote on the pending,
VANCOUVER, BC, May 11, 2015 (GLOBE NEWSWIRE) — via PRWEB – According to a recently published report by iData Research (http://www.idataresearch.com), the orthopedic stem cell market was the fastest growing orthopedic biomaterial segment in the US. It aims to provide
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1